LT - CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE
EN - CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07D 471/04 |
|
|
|
A61K 31/4745 |
|
|
|
A61P 35/00 |
|
European patent
(11) |
Number of the document |
2094700 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
07864492.9 |
|
Date of filing the European patent application |
2007-11-16 |
(97) |
Date of publication of the European application |
2009-09-02 |
(45) |
Date of publication and mention of the grant of the patent |
2014-04-02
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/US2007/084893 |
|
Date |
2007-11-16 |
PCT application publication
(87) |
Number |
WO 2008/064093 |
|
Date |
2008-05-29 |
Priority applications
(30) |
Number |
Date |
Country code |
|
866483 P |
2006-11-20
|
US |
Inventors
(72) |
STOWASSER, Frank, DE
BÄNZIGER, Markus, CH
GARAD, Sudhakar Devidasrao, US
|
Grantee
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Title
(54) |
CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE |
|
CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE |